Patents by Inventor Aristo Wojdani

Aristo Wojdani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5275814
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: January 4, 1994
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Patent number: 5116612
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: June 7, 1990
    Date of Patent: May 26, 1992
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Patent number: 5049390
    Abstract: An immunotherapy agent for the treatment of allergy composed of an allergen encapsulated in or covalently bound to a liposome is disclosed. Use of the agent in immunotherapy results in enhanced IgG production and reduced IgE production.
    Type: Grant
    Filed: April 25, 1990
    Date of Patent: September 17, 1991
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani
  • Patent number: 4946945
    Abstract: A protein conjugate or mixture useful in immunotherapy composed of a biological response modifier (BRM) and an allergen is disclosed. In use the protein conjugate or mixture is combined with a pharmaceutically acceptable carrier. Cytokines, bacterial, fungal and viral immunopotentiators and thymus hormones are disclosed as suitable BRM's for use in the invention.
    Type: Grant
    Filed: June 23, 1987
    Date of Patent: August 7, 1990
    Assignee: Allergy Immuno Technologies, Inc.
    Inventor: Aristo Wojdani